Saidal

From Wikipedia, the free encyclopedia
Saidal Group
Native name
مجمع صيدال
TypeState-owned company
Industrypharmaceuticals
Founded1982; 39 years ago (1982)
Headquarters,
Productsantibiotics, generics
Production output
pharmaceuticals
RevenueUS$982 million (2006)
Number of employees
4,300 (2006)
Websitewww.saidalgroup.dz

Saidal Group is an Algerian pharmaceutical company created in 1982. Saidal Group is the largest pharmaceutical company in Algeria and one of the largest in Africa.

Saidal Group exports its products to Ivory Coast, Gabon, Senegal, Cameroon, Mali, Democratic Republic of the Congo, Republic of the Congo, Niger, Togo, Benin, Guinea-Bissau, Chad and Mauritania.[1]

History[]

Saïdal was created in April 1982 following the restructuring of the Algerian Central Pharmacy. In 1985, it changed its name to become Saidal.

In 1989, Saidal became an economic public company, one of the first national company to acquire the status of joint stock company in 1993. In 1997, Saidal was transformed into an industrial group, which Biotic, Pharmal and Antibiotical were attached.[2]

January 4, 2016, the national bioequivalence center, the first in Algeria, was inaugurated by the Minister of Industry and Mines, Abdeslam Bouchouareb.[3]

Company management[]

Saïdal is headed by :

  • Boumediene Derkaoui (2010-2015)
  • Mohamed Hammouche (2015-2016)
  • Yacine Tounsi (2016-2017)
  • Mohamed Nouas (2017-2020)
  • Fatouma Akacem since February 11, 2020[4]

References[]

  1. ^ https://www.huffpostmaghreb.com/2016/05/18/saidal-produits-_n_10017054.html
  2. ^ "Saidal : Un groupe aux grandes ambitions". www.elmoudjahid.com.
  3. ^ "الإذاعة الجزائرية". www.radioalgerie.dz (in Arabic). Retrieved 2020-04-29.
  4. ^ Mounia, Boudjedri. "Mme Fatouma Akacem installée dans ses nouvelles fonctions de PDG de Saïdal". www.aps.dz (in French). Retrieved 2020-04-29.

External links[]


Retrieved from ""